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xin is a component of the canonical Wnt pathway
that negatively regulates signal transduction by
 
promoting degradation of 
 
 
 
-catenin. To study the
role of Axin in development, we developed strains of
transgenic mice in which its expression can be manipulated
by the administration of doxycycline (Dox). Animals carrying
both mouse mammary tumor virus (MMTV)–reverse tetra-
cycline transactivator and tetracycline response element
(TRE)2–Axin–green ﬂuorescent protein (GFP) transgenes
exhibited Dox-dependent Axin expression and, when in-
duced from birth, displayed abnormalities in the development
of mammary glands and lymphoid tissues, both sites in
 
which the MMTV promoter is active. The transgenic
mammary glands underwent normal ductal elongation
A
 
and side branching during sexual maturation and early
pregnancy, but failed to develop lobulo-alveoli, resulting
in a defect in lactation. Axin attenuated the expression
 
of cyclin D1, a Wnt target that promotes the growth
and differentiation of mammary lobulo-alveoli. Increased
apoptosis occurred in the mammary epithelia, consistent
with the inhibition of a Wnt/cyclin D1 survival signal by
Axin. High levels of programmed cell death also occurred
in the thymus and spleen. Immature thymocytes underwent
massive apoptosis, indicating that the overexpression of
Axin blocks the normal development of T lymphocytes.
Our data imply that the Axin tumor suppressor controls cell
survival, growth, and differentiation through the regulation
of an apoptotic signaling pathway.
 
Introduction
 
Axin was first identified as a negative regulator of embryonic
axis formation, exerting its effects by modulating the Wnt
signal transduction pathway (Zeng et al., 1997). Substantial
evidence from several laboratories has since revealed that Axin
 
plays a central role in regulating the stability of 
 
 
 
-catenin, a
crucial event in cellular responses to Wnt signaling (reviewed
in Miller et al., 1999; Kikuchi, 2000; Peifer and Polakis,
2000). Distinct functional domains of Axin mediate its
interaction with several Wnt signaling molecules, including
disheveled, the serine/threonine kinase GSK-3
 
 
 
, 
 
 
 
-catenin,
adenomatous polyposis coli (APC),* and the serine/threonine
phosphatase PP2A
 
c
 
 (Behrens et al., 1998; Fagotto et al.,
1999; Hsu et al., 1999; Kikuchi, 2000). In the absence of a
Wnt signal, 
 
 
 
-catenin forms a complex including Axin,
APC, and GSK-3
 
 
 
, leading to its phosphorylation by GSK-3
 
 
 
and degradation through the ubiquitin-dependent proteolysis
system (Aberle et al., 1997; Hart et al., 1998; Farr et al.,
2000). Wnt signals perturb the formation of this complex by
activating the upstream regulators, disheveled, casein kinase
I
 
 
 
, and GBP/Frat1 (Li et al., 1999; Peters et al., 1999;
Smalley et al., 1999; Willert et al., 1999; Julius et al., 2000;
Kikuchi, 2000). Thus, 
 
 
 
-catenin is protected from phos-
phorylation and consequent degradation. The downstream
signaling events are triggered by the accumulation of nuclear
 
 
 
-catenin, which interacts with transcription factors of the
lymphoid enhancer factor/T cell factor (LEF/TCF) family
(Behrens et al., 1996; Molenaar et al., 1996) to regulate
target genes, such as cyclin D1, c-myc, and c-jun (He et al.,
1998; Mann et al., 1999; Shtutman et al., 1999; Tetsu and
McCormick, 1999). In addition to its interaction with
components of the Wnt pathway, Axin has been shown to
 
activate the c-Jun NH
 
2
 
-terminal kinase/stress-activated
protein kinase (JNK/SAPK) signaling cascade through
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domains distinct from those regulating Wnt/
 
 
 
-catenin
(Zhang et al., 1999).
Members of the Wnt family are important for diverse pro-
cesses during embryonic, fetal, and postnatal development,
including the development of the embryonic axis, central
nervous system, limbs, reproductive tract, kidneys, and
mammary glands (reviewed in Wodarz and Nusse, 1998).
Furthermore, several Wnt signaling molecules have been im-
plicated in the development of different forms of cancer (re-
viewed in Behrens, 2000; Polakis, 2000). For instance,
mammary gland tumors develop in transgenic mice with ele-
vated expression of Wnt-1, Wnt-10b, or the Wnt target
gene cyclin D1 (Tsukamoto et al., 1988; Wang et al., 1994;
Lane and Leder, 1997). The development of colorectal can-
cers is commonly initiated by mutations of APC in humans
and mice (reviewed in Behrens, 2000; Polakis, 2000). Ex-
pression of a stabilized form of 
 
 
 
-catenin can lead to the for-
mation of hair follicle and mammary tumors in transgenic
mice (Gat et al., 1998; Imbert et al., 2001), and mutations
affecting the stability of 
 
 
 
-catenin have been identified in
human malignancies (reviewed in Polakis, 2000). Finally,
the recent finding that Axin is mutated in hepatocellular car-
cinomas suggests that it acts as a tumor suppressor (Satoh et
al., 2000).
Although some understanding of the role of Axin in early
mouse embryogenesis has been gained through studying loss
of function mutations (Gluecksohn-Schoenheimer, 1949;
Jacobs-Cohen et al., 1984; Perry et al., 1995; Zeng et al.,
1997), its role in later developmental events mediated by
Wnt signals is unclear, in part because of the early embry-
onic lethality of Axin mutants. To further investigate the
role of Axin in mammalian development and tumorigenesis,
we have developed bi-transgenic strains of mice in which the
overexpression of Axin can be induced in several tissues, us-
ing the tetracycline-dependent activation system (Gossen et
al., 1995). We have used these mice to examine the conse-
quences of Axin overexpression in the postnatal develop-
ment of the mammary gland and lymphoid tissues. Our re-
sults imply that the Axin tumor suppressor plays a role in
cell survival, growth, and differentiation through the regula-
tion of an apoptotic signaling pathway.
 
Results
 
Regulated expression of Axin in transgenic mice
 
To investigate the potential ability of Axin to regulate Wnt
signal transduction during mammary gland development
and tumorigenesis, Axin was expressed in transgenic mice
using the promoter/enhancer of mouse mammary tumor vi-
rus (MMTV). Initial attempts to establish lines of mice ex-
pressing an MMTV–Axin transgene were unsuccessful (un-
published data). We suspected this might be due to pre- or
perinatal lethal effects of the transgene, since the MMTV
promoter/enhancer is active in several tissues in addition to
the mammary gland (Hennighausen et al., 1995). We there-
fore attempted to express Axin using a tetracycline-depen-
dent activation system, which had been successfully used for
conditional gene expression in eukaryotic cells and in vari-
ous tissues of mice (reviewed in Saez et al., 1997). In this
system, three components are required to achieve tetracy-
cline-dependent expression. First, the reverse tetracycline
transactivator (rtTA), a fusion of tet-repressor DNA binding
domain and VP16 transcriptional activation domain, is ex-
pressed in a tissue- or cell-specific pattern, using appropriate
regulatory sequences. Second, a tetracycline response ele-
ment (TRE) is used to control expression of the target gene.
Third, the drug doxycycline (Dox), which can be adminis-
tered in a temporally specific fashion, induces rtTA to bind
to the TRE, turning on the expression of the target gene
(Gossen et al., 1995).
Figure 1. DNA constructs used for Dox-inducible expression of 
Axin and analyses of rtTA and Axin expression in transgenic mice. 
(A) TRE2–Axin–GFP consisted of a tetracycline responsive element 
(TRE2), the myc-tagged, full-length mouse Axin coding sequence, 
IRES2, and the enhanced GFP. MMTV–rtTA consisted of the MMTV 
LTR and rtTA coding sequence. Both constructs included noncoding 
exon2, intron, exon3, and polyadenylation sequences of h G. (B) 
Expression of rtTA in tissues of MMTV–rtTA transgenic mice (line 
MTA4) was analyzed by RT-PCR using primers (arrows) within the 
rtTA coding region and noncoding exon 3 of h G, which are
specific for the spliced form of the mRNA. Strong signals were
detected in Mg, Sg, Ty, and Te, whereas a weak signal was
consistently observed in Sp. Expression of the housekeeping gene 
Hprt was used as a control. (C) Protein lysates from the mammary 
gland (16.5 dpc) and thymus (3 mo) of control and DDTg mice were 
immunostained with anti-Axin antibody. The endogenous Axin with 
an apparent molecular mass of 120 and 140 kD were detected in 
both control and DDTg lysates. Extracts from DDTg mice contained 
an additional transgenic MT–Axin protein (Tg). The increased size 
of MT–Axin is due to the myc-tag and to additional NH2-terminal 
sequences encoded by the full-length Axin cDNA that are not
translated in the most abundant endogenous form of Axin. Mg, 
mammary gland; Sg, salivary gland; Ty, thymus; Te, testis; In,
intestine; He, heart; Li, liver; Lu, lung; Sp, spleen. 
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To express Axin in a tetracycline-dependent manner, the
two DNA constructs MMTV–rtTA and TRE2–Axin–green
fluorescent protein (GFP) (Fig. 1 A) were used separately to
generate transgenic mice (see Materials and methods for de-
tails). For easier detection of transgene expression, a myc
epitope tag (MT) was inserted at the amino terminus of
Axin. The enhanced GFP was included under the control of
an internal ribosomal entry sequence (IRES2) as an addi-
tional reporter for expression of the Axin transgene (Fig. 1
A). One MMTV–rtTA transgenic line (MTA4), which was
used for the studies reported here, expressed rtTA mRNA
strongly in the mammary gland, salivary gland, thymus, and
testis, weakly but consistently in the spleen, and not detect-
ably in the intestine, heart, liver, or lung, as determined by
RT-PCR analysis (Fig. 1 B).
Two different TRE2–Axin–GFP lines, TA11 and TA32,
were used in these studies. By crossing either of these lines
with MTA4 (in the absence of Dox induction), we were able
to obtain the double transgenic mice, which were born with-
out any obvious defects. To induce the expression of MT–
Axin and GFP in these offspring, their mothers were fed
Dox in the drinking water starting at the time of parturition,
and the offspring were maintained on Dox throughout their
lives. Expression of MT–Axin and GFP, as well as pheno-
typic abnormalities, were only observed in the Dox-induced
double transgenic offspring (hereafter referred to as DDTg
mice), and never in single transgenic siblings treated with
Dox, or double transgenics in the absence of Dox (unpub-
lished data). DDTg mice derived from lines TA11 and
TA32 expressed MT–Axin and GFP both in the testes and
mammary glands, whereas only line TA32 showed expres-
sion in the thymus (see Fig. 6 A). Therefore, both TA lines
were used for mammary gland analyses, whereas line TA32
was used to study the effects of Axin in lymphoid organs.
Western blot analyses with anti-Axin antiserum detected a
novel MT–Axin protein in the mammary gland and thymus
of DDTg mice, in addition to the endogenous Axin proteins
of 120 and 140 kD in control tissues (Fig. 1 C). The trans-
genic MT–Axin protein was expressed at 1.5 and 2.5 the
level of endogenous Axin in mammary gland and thymus,
respectively. Approximately 40% of DDTg mice derived
from line TA32 died at 
 
 
 
3 wk of age (with Dox treatment
starting at the day of birth), whereas those from line TA11
rarely died prematurely. The cause of death in these animals
has not been determined, and most of the mice that survived
this critical period went on to live to adulthood.
 
Dox-induced overexpression of Axin inhibits the 
development of lactating mammary gland
 
DDTg females, which had been induced with Dox since
birth, were mated to wild-type males to assess the effects of
Axin overexpression on the postnatal phases of mammary
gland development. We studied mammary gland develop-
ment in a total of 16 DDTg mice, including 12 from line
TA11 and 4 from line TA32. An anomaly in mammary
gland function was observed soon after they delivered their
litters (Fig. 2). In the newborn pups of control females, in-
cluding TA/MTA double transgenic mice without Dox in-
duction (Fig. 2 A, animal on the left), the stomachs filled
with milk could be seen clearly through the body wall.
However, when DDTg females were maintained on Dox
throughout their pregnancy the stomachs of all their pups
appeared empty (Fig. 2 A, two pups on the right), suggesting
a deficiency in lactation. The pups were otherwise normal,
as they could be rescued by fostering to normal, lactating fe-
males.
The mammary epithelium develops during three phases:
fetal development, puberty, and pregnancy (reviewed in
Sakakura, 1991). In female fetuses, the mammary buds de-
velop beginning at E12, they become mammary sprouts at
E16, and by birth each has ramified into a small mammary
gland tree with 15–20 branching ducts. The gland then re-
mains static until puberty. During sexual maturation, the
distal end of each duct grows and forms a terminal end bud,
a specialized and highly proliferative epithelial structure.
The end bud elongates and ramifies to form the mammary
ductal tree system, which spreads throughout the fatty
stroma. Finally, during pregnancy, the mammary epithelial
ducts form side branches that develop into lobulo-alveolar
structures, eventually filling the entire mammary fat pad. In
a histological section of normal lactating mammary gland,
the stroma is densely packed with alveolar lobules, which are
well extended and filled with milk (Fig. 2 B). However, the
lactating mammary glands of DDTg females showed severe
hypoplasia of the lobulo-alveoli (Fig. 2 C; 
 
n 
 
  
 
6, four from
line TA11 and two from line TA32). They were very small
in diameter and contained little if any milk. This hypoplas-
tic alveolar development was accompanied by a deficiency in
terminal differentiation of mammary epithelia, as shown by
Figure 2. Dox-induced expression of Axin inhibits maturation of 
the mammary gland. (A) In a pup born to a control female (left) the 
stomach filled with milk is clearly visible (arrowhead). In two pups 
born to a female DDTg mouse (center and right) no milk was visible 
in the stomachs. (B and C) Hematoxylin- and eosin-stained sections 
of mouse mammary glands at 2 d postpartum. In a control mouse 
(B), the lobulo-alveoli were fully developed and lactation effects 
were seen. In a DDTg mouse at 2 d postpartum (C), there was
hypoplastic development of lobulo-alveoli with very little lactation. 
(D) Immunoblot analyses showed the expression of casein, a marker 
for terminally differentiated mammary epithelium, in mammary 
glands at various developmental stages (lane 1, 2-mo-old virgin; 
lane 2, 9.5 dpc; lane 3, 16.5 dpc). K14 was also analyzed as a control 
for epithelial cell content of the mammary glands. Bars, 250  m. 
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reduction in expression of the milk protein, casein, at late
pregnancy (Fig. 2 D).
A more thorough examination of mammary gland devel-
opment in DDTg females by whole mount staining showed
that the mammary ductal tree system developed normally,
and that side branching had occurred at mid-pregnancy
(8.5 d postcoitum [dpc]) to an extent comparable to controls
(Fig. 3, A–F; 
 
n 
 
 
 
 3, line TA11). However, late in pregnancy
(16.5 dpc), although the number of side branches had fur-
ther increased in DDTg females, the maturation of mam-
mary tissue was severely impaired, with an absence of lob-
ulo-alveolar structures (Fig. 3, G–L; 
 
n 
 
  
 
5, three from line
TA11 and two from line TA32). Although the DDTg mam-
mary glands had developed small numbers of alveoli, they
never matched the size and density of those in control mice.
The same abnormalities were observed when Dox was ad-
ministrated starting at the beginning of pregnancy, ruling
out the possibility that the defects were a result of Axin over-
expression during prenatal development or sexual matura-
tion (unpublished data; 
 
n 
 
  
 
3, two from line TA11 and one
from line TA32) This phenotypic defect could also be re-
versed after the withdrawal of Dox, as shown by successful
lactation with later litters, indicating that it was caused by
the Dox-induced expression of Axin during pregnancy and
lactation. The expression of the transgene-encoded MT–
Axin protein in DDTg mammary gland epithelia was con-
firmed by immunostaining with anti-myc antibody (Fig. 4),
and was consistent with the expression pattern expected
for the MMTV promoter/enhancer (Hennighausen et al.,
1995). Therefore, elevated expression of Axin in mammary
epithelia appeared to inhibit mammary gland development
at a late stage of pregnancy.
The defects in mammary gland development in the
DDTg mice were remarkably similar to those in mice lack-
ing cyclin D1, in which the mammary epithelium also un-
dergoes normal elongation and side branching, but fails to
form alveolar lobules (Fantl et al., 1995; Sicinski et al.,
1995). As cyclin D1 has been identified as a bona fide target
gene of the Wnt/
 
 
 
-catenin signaling pathway (Shtutman et
al., 1999; Tetsu and McCormick, 1999), we examined the
possible inhibitory effects of Axin on Wnt signaling. Even
though high levels of cytoplasmic 
 
 
 
-catenin were consis-
tently exhibited in normal epithelia of developing mammary
alveoli (Fig. 5 A), the DDTg mice showed relatively lower
levels of 
 
 
 
-catenin at the same stage (Fig. 5 B, 
 
n 
 
  
 
3). In
normal mammary epithelia undergoing alveolar develop-
ment, cyclin D1 was uniformly and strongly expressed, as
revealed by immunostaining (Fig. 5 C). However, its expres-
sion was significantly reduced in the mammary epithelia of
DDTg mice (Fig. 5 D, 
 
n 
 
  
 
2). Immunoblot analyses
showed an approximately ninefold reduction of the steady-
state level of cyclin D1 in the mammary gland of DDTg
mice (Fig. 5 E). Therefore, the inhibitory effects of MT–
Axin on alveolar development in the lactating mammary
Figure 3. Defective development of 
mammary gland at late pregnancy in 
DDTg mice. Whole mount staining of 
the number four mammary glands
revealed no significant differences in 
ductal elongation or side branching
between control (A–C) and DDTg (D–F) 
mice at mid-pregnancy (8.5 dpc). 
However, at late pregnancy (16.5 dpc), 
although the DDTg mammary epithelia 
showed continued side branching, their 
alveolar development was severely
hypoplastic (J–L) as compared with
controls at the same stage (G–I). Bars: (A, 
D, G, and J) 3 mm ; (B, E, H, and K) 1 mm; 
(C, F, I, and L) 250  m .
Figure 4. Inducible expression of Axin in the mammary gland
epithelia of DDTg mice. Immunohistochemical staining with an 
anti-myc antibody localized MT–Axin to the epithelia of mammary 
glands in DDTg mice (B and D). The mammary glands of control 
mice showed only background staining (A and C). (A and B) 8.5 dpc; 
(C and D) 2 d postpartum. Bars, 125  m. 
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gland may be mediated, at least in part, by its effects on the
Wnt-induced expression of cyclin D1.
In addition to the repression of mammary epithelial
growth and differentiation, the inhibition of Wnt/cyclin D1
signaling by overexpression of Axin could also result in defi-
ciencies in cell survival. TdT-mediated dUTP nick end la-
beling (TUNEL) analyses revealed a large increase in the
number of apoptotic cells in the mammary epithelia of
DDTg mice, indicating that programmed cell death con-
tributed to the observed hypoplastic development of this or-
gan (Fig. 5, F and G; 
 
n 
 
  
 
2).
 
Dox-induced overexpression of Axin interferes with 
normal thymic development
 
Histological analyses of the DDTg mice that died at about 3
wk of age revealed no abnormalities in the heart, intestine,
kidney, liver, lung, pancreas, salivary gland, skin, or testes.
However, all of the DDTg mice (derived from TRE2–Axin–
GFP line TA32), even those that survived, shared a defect in
the thymus, which was much smaller than in normal mice at
the same age. We analyzed a total of 10 DDTg animals, 6 at
3 mo and 4 at 4 mo of age. The thymus was one of the tis-
sues that expressed rtTA at high levels in MMTV–rtTA
transgenic mice (Fig. 1 B), and the Dox-inducible TRE–
Axin–GFP transgene was also expressed in this tissue, as in-
dicated by whole mount fluorescence microscopy (Fig. 1 C
and Fig. 6 A).
The progenitors of T cells originate in the bone marrow
and arrive at the thymus where they develop into mature
thymocytes (for review see Paul, 1999). A normal thymus
has two lobes (left and right), each containing several lob-
ules, which are further divided into cortical and medullary
regions. The cortex contains many immature and resting
thymocytes that express low levels of the T cell marker CD3.
Mature thymocytes express high levels of CD3 and reside in
medulla, an epithelial enriched environment (Paul, 1999).
Histological analyses of thymus from DDTg mice re-
vealed a lack of normal organization. In normal 3-wk-old
mice (Fig. 6 D), the thymic lobules are characterized by a
darkly stained cortex and a lightly stained medulla. In con-
trast, the thymuses of 3-wk-old DDTg mice showed no sep-
arate lobules within a lobe and had no discernible cortex and
medulla (Fig. 6 E; 
 
n 
 
  
 
6). In 4-wk-old DDTg mice, these
defects were similar except that the thymus was even smaller
in size (Fig. 6 F; 
 
n 
 
  
 
4).
The medulla and cortex could be easily distinguished by
staining the epithelia with anticytokeratin antibodies and
the thymocytes with methyl green (Fig. 6 G). The thy-
mocyte-enriched cortical region was absent in the thy-
muses of 3- and 4-wk-old DDTg mice (Fig. 6, H and I),
implying the loss of immature thymocytes that normally
reside in the cortex. Because the expression of CD3 is low
in immature thymocytes and high in mature thymocytes
(Paul, 1999), CD3 staining was also used to differentiate
these two cell types and regions. In control thymus, ma-
ture thymocytes in the medulla stained more darkly,
whereas immature thymocytes in the cortex showed
lighter staining (Fig. 6 B). This method confirmed that
the immature thymocyte–enriched cortical region was lost
in DDTg mice (Fig. 6 C).
Figure 5. Reduced  -catenin and cyclin D1 expression and
increased apoptosis in lactating mammary gland epithelia of DDTg 
mice. (A and B) Sections were immunostained with an anti- –catenin 
antibody (red staining), and counterstained with hematoxylin
(blue staining). (A) High levels of cytoplasmic  -catenin (arrow-
heads) were observed in normal epithelia of lactating mammary 
gland at 2 d postpartum. (B) The mammary gland of DDTg mice at 
2 d postpartum showed reduced levels of  -catenin. (C and D)
Immunohistochemical staining with an anti-cyclin D1 antibody
revealed a reduced level of cyclin D1 expression in the epithelia 
of lactating mammary gland at 2 d postpartum. (C) The lactating 
mammary gland of a control mouse showed intense and uniform 
staining. (D) Mammary epithelia of DDTg mice showed reduced 
staining and, in some areas (indicated by arrowheads), lack
of staining above background levels. (E) Protein lysates from con-
trol and DDTg mammary gland at 17.5 dpc were immunostained 
with (left) anti-myc antibody to detect transgenic expression of
MT–Axin, (center) anti-K14 (50 kD) antibody, serving as a control 
of the epithelial cell content of the mammary gland, and (right) anti-
cyclin D1 antibody. The level of cyclin D1 (36 kD) was ninefold 
reduced in the DDTg mammary epithelia compared with the con-
trol, after normalization for K14 levels. The positions of protein 
molecular weight markers are indicated at the left. Arrowheads in-
dicate the presence of the specific protein bands and the asterisk 
indicates nonspecific bands. (F and G) TUNEL staining of control 
(F) and DDTg (G) mouse mammary glands at 2 d postpartum. The
epithelia of DDTg lactating mammary gland displayed increased 
numbers of apoptotic cells. Bars: (A and B) 62.5  m; (C, D, F, 
and G) 125  m. 
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The paucity of immature thymocytes in the thymus sug-
gested that expression of Axin in the DDTg mice might
have induced apoptosis of these cells. Indeed, large numbers
of apoptotic thymocytes with fragmented nuclei were ob-
served in the thymic cortex of 3-wk-old DDTg mice (Fig. 7,
A and B). Whereas programmed cell death occurs normally
during the maturation of thymocytes (Sebzda et al., 1999),
TUNEL staining confirmed that there was a massive in-
crease in apoptosis in the thymuses of DDTg mice, espe-
cially in the cortical region (Fig. 7, C and D). We also exam-
ined other lymphoid organs for the presence of apoptotic
cells, and observed increased apoptosis and decreased num-
bers of lymphocytes in the spleen (Fig. 7, E–H) and lymph
nodes (unpublished data), although the effect was not as se-
vere as in the thymus.
 
Discussion
 
An important role of Axin in early embryogenesis has been
demonstrated through the analysis of loss of function mu-
tants in mice (Zeng et al., 1997) and zebra fish (Heisenberg
et al., 2001) as well as expression of wild-type and domi-
nant-negative forms in frog embryos (Zeng et al., 1997; Itoh
et al., 1998; Fagotto et al., 1999). However, little is known
about the role of Axin in later developmental events, e.g., its
capacity to negatively regulate many Wnt-mediated signal-
ing events during fetal and postnatal development. Axin has
also been implicated as a tumor suppressor, based on its mu-
tation in human hepatocellular carcinoma (Satoh et al.,
2000). However, the mechanism of its function as a tumor
suppressor has not yet been investigated in an animal model.
One approach to these questions, which we describe in this
paper, is to generate transgenic mice in which the expression
of wild-type Axin (or, potentially, mutant forms) can be in-
duced to high levels in a regulated manner. We have devel-
oped MMTV–rtTA and TRE2–Axin–GFP transgenic lines
that, when crossed, produce bitransgenic animals in which
Axin can be induced in several tissues by administering Dox.
We have used this system to examine the consequences of
Axin overexpression in two tissue types where the Wnt/
 
 
 
-
catenin/LEF-Tcf signaling pathway is known to play impor-
tant roles, the mammary gland and the lymphoid tissues.
The Wnt signal transduction pathway has been implicated
in the pregnancy-dependent development, as well as neo-
plastic transformation, of the mouse mammary gland. The
earliest evidence implicating Wnts in these processes was the
finding that Wnt-1 and Wnt-3 were activated by the inser-
tion of MMTV proviruses in mouse mammary carcinomas
(Nusse and Varmus, 1992). Transgenic mice that constitu-
tively expressed Wnt-1 or Wnt-10b under the control of the
MMTV long terminal repeat (LTR) displayed hyperplastic
mammary epithelia, with premature side branching and lob-
ulo-alveolar development in virgin females (and estrogen-
independent mammary ductal morphogenesis in males),
eventually progressing to mammary adenocarcinomas (Tsu-
kamoto et al., 1988; Lane and Leder, 1997). Wnt-1 is also
able to induce branching morphogenesis of cultured mam-
mary epithelial cells (Uyttendaele et al., 1998). These find-
ings implied that Wnt signaling can stimulate the survival,
growth, and differentiation of mammary epithelial cells, and
that aberrant activation of this pathway results in hyperplas-
tic development and oncogenic transformation. It should
Figure 6. Elevated expression of Axin 
affects development of thymus. (A) 
Whole mount fluorescence microscopy 
of control thymus (left) and thymus from 
a 3-wk-old DDTg mouse (right). GFP
expression is visible only in the DDTg 
thymus. No fluorescence above back-
ground was observed in nontransgenic 
or single TRE2–Axin–GFP transgenic 
mice, or in double transgenic mice
without Dox administration (unpublished 
data). (D–F) Hematoxylin- and eosin-
stained sections of thymus from a
3-wk-old control mouse (D), a 3-wk-old 
DDTg mouse (E), and a 4-wk-old DDTg 
mouse (F). Immunohistological staining 
of thymus was performed with anti-CD3 
(B and C) or anti-pan cytokeratin (G–I) 
antibody. (G–I) Sections were stained 
with anti-cytokeratin antibodies in 
brown color to mark the thymic epithelia, 
whereas thymocytes were counterstained 
with methyl green. In a control mouse 
(G), the medulla showed heavy brown 
staining, whereas the green stain
indicated the many immature thymocytes 
in the cortex. In the thymus of a 3-wk-old 
(H) and a 4-wk-old (I) DDTg mouse, the 
thymocyte-enriched cortex had disappeared. The T cell marker CD3 is expressed highly in mature thymocytes and weakly in immature
thymocytes. This marker distinguished the medulla (m) from cortex (c) in a normal, 4-wk-old thymus (B). However, in the thymus of 4-wk-old 
DDTg mice, no distinguishable regions could be observed, indicating a loss of the cortical region and a dramatic decrease in the population 
of thymocytes expressing low levels of CD3 (C). Bars: (A, G, H, and I) 250  m; (B and C) 125  m; (D–F) 1 mm. 
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also be noted that this pathway plays an important role dur-
ing the earliest fetal stages of mammary gland development,
as shown by the absence of mammary glands in LEF-1 mu-
tant mice (van Genderen et al., 1994).
Several members of the Wnt family are expressed at vari-
ous stages of normal mammary gland development, includ-
ing Wnt-4, -5b, -6, -7b, and -10b in the epithelium and
Wnt-2, -5a, and -6 in the stromal compartment (for review
see Robinson et al., 2000). This raises the possibility that
some Wnts may mediate epithelial induction by the stroma,
whereas others may serve in an autocrine pathway. To date,
the only member of the Wnt family whose role in mammary
gland development has been evaluated using a null muta-
tion is Wnt-4, which is expressed in the mammary epithe-
 
lium during early to mid-pregnancy. In these experi-
ments (Brisken et al., 2000), mammary buds from E14.5
Wnt4
 
 
 
/
 
 
 
 fetuses (which die perinatally) were transplanted
into wild-type mice, where their subsequent development
could be assessed. The mutant mammary glands showed a
specific defect in progesterone-induced ductal side branch-
ing early in pregnancy, indicating that Wnt-4 functions
downstream of progesterone signaling in this process. How-
ever, at later stages of pregnancy, the mutant epithelia exhib-
ited a more normal pattern of branching and alveolar devel-
opment, suggesting that other members of the Wnt family
expressed later in mammary gland development may eventu-
ally compensate for the lack of Wnt-4 (Brisken et al., 2000).
In the present study, we have shown that the induced
overexpression of Axin in the mammary epithelium of
DDTg mice interferes with the later phases of mammary
gland development. The gland develops normally during the
early stages of pregnancy, forming a normal ductal tree sys-
tem and undergoing extensive side branching. Thus, Axin
overexpression does not appear to interfere with the Wnt-4–
mediated signaling events, which are required specifically for
lateral branching during mid-pregnancy (Brisken et al.,
2000). However, later in pregnancy the maturation of
DDTg mammary tissue is severely impaired, with the ab-
sence of mature lobulo-alveolar structures and a failure of
lactation. Given the established activity of Axin as a negative
regulator of the canonical Wnt/
 
 
 
-catenin pathway, it is
likely that Axin is interfering with a Wnt signaling event re-
quired for alveolar development. Interestingly, the lack of an
effect of Axin on ductal side branching is consistent with ev-
idence that Wnt-4 may signal through an alternative path-
way (Kuhl et al., 2000) rather than the canonical Wnt/
 
 
 
-
catenin pathway (Shimizu et al., 1997; Wong et al., 1994).
If Wnt-4 signaled through the canonical Wnt/
 
 
 
-catenin
pathway, it is likely that overexpression of Axin would have
also had an effect during the stage of mammary gland devel-
opment at which Wnt-4 is required.
Although the mechanisms by which various Wnts con-
tribute to the control of mammary gland development are
poorly understood, one downstream gene that appears to
play an important role is cyclin D1. The cyclin D1 gene has
been identified as a target of the canonical Wnt pathway,
which is activated by 
 
 
 
-catenin and TCF/LEF factors
(Shtutman et al., 1999; Tetsu and McCormick, 1999). In mice
with a targeted mutation in cyclin D1, the mammary ductal
tree developed normally and formed many side branches
early in pregnancy, however there was a dramatic impair-
ment in the expansion of mammary epithelium and devel-
opment of alveolar lobules in late pregnancy (Fantl et al.,
1999). In the DDTg mice, we found that high levels of Axin
appeared to reduce the accumulation of cytoplasmic 
 
 
 
-cate-
nin in the mammary epithelia. The expression of cyclin D1
in these cells was also greatly reduced, and the mammary
gland phenotype was very similar to that of the cyclin D1
knockout mice. Thus, we propose that Axin can inhibit a
Wnt-mediated signal required for the expression of cyclin
D1 (Fig. 8). We also observed an increased number of apop-
totic cells in the mammary epithelia of DDTg mice, suggest-
ing that a Wnt signal inhibited by Axin normally provides a
survival signal for these cells. This result is consistent with
Figure 7. Axin induces extensive apoptosis in the lymphocytes of 
DDTg mice. Hematoxylin and eosin staining (A, B, E, and F) and 
TUNEL staining (C, D, G, and H) were performed on sections of
thymus (A–D) and spleen (E–H) of 3-wk-old mice. Lymphocytes 
were normally packed in the thymus (A) and spleen (E) of control 
mice. Fragmented nuclei were identified in the thymus (B) and 
spleen (F) of 3-wk-old DDTg mice. The insets display magnified
images revealing the nuclear morphology. In the TUNEL assay, high 
levels of apoptotic signals were detected in the thymus (D) and 
spleen (H) of DDTg mice. Background levels of apoptosis were
observed in the thymus (C) and spleen (G) of control mice. Bars: (A, 
B, and E–H) 62.5  m; (C and D) 250  m. 
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recent reports that Wnt signaling may inhibit apoptosis
through a 
 
 
 
-catenin/Tcf-dependent mechanism in addition
to promoting cell growth and proliferation (Bournat et al.,
2000; Reya et al., 2000; Chen et al., 2001; Ioannidis et al.,
2001). The ability of cyclin D1 to prevent programmed cell
death may also play a role in Wnt-mediated, anti-apoptotic
effects (Albanese et al., 1999).
Expression of Axin under the MMTV promoter/enhancer
also caused abnormal development of the thymus, with a mas-
sive apoptosis of immature thymocytes. The progenitors of T
cells are CD4-, CD8- double-negative thymocytes, which dif-
ferentiate into double-positive cells, the largest cell population
in the thymus. Double-positive thymocytes rest in the cortex
and await signals to develop into single-positive, mature thy-
mocytes bearing either CD4 or CD8. The maturation of thy-
mocytes depends critically on the survival and death of imma-
ture thymocytes during a series of clonal selections, which
ensure the generation of an effective immune response with-
out autoimmune reactivity (for review see Sebzda et al.,
1999). Although apoptosis is a normal mechanism of clonal
selection, the level of apoptosis observed in the thymuses of
DDTg mice was greatly elevated, suggesting that overexpres-
sion of Axin can interfere with a signaling pathway that regu-
lates thymocyte survival. The spleens of these mice also con-
tained a decreased number of lymphocytes. This might be due
in part to the reduced number of thymocytes, which migrate
to the spleen during their circulation, although increased
apoptosis was also observed in the spleen itself.
It is possible that Axin promotes the apoptosis of lym-
phoid cells through its ability to negatively regulate the ca-
nonical Wnt signaling pathway. Although little is known
about the participation of Wnts in the development of lym-
phocytes, the LEF/TCF family of transcription factors was
originally identified through its role in the regulation of
 
lymphocyte-specific genes (Travis et al., 1991; van de We-
tering et al., 1991; Waterman et al., 1991). Furthermore, re-
cent evidence suggests that Wnt signaling regulates the
survival and differentiation of double-positive thymocytes
through a 
 
 
 
-catenin and LEF/TCF-dependent mechanism
(Gounari et al., 2001; Ioannidis et al., 2001). TCF-1–defi-
cient mice show a drastic decrease in the number of double-
positive thymocytes (Verbeek et al., 1995), a phenomenon
similar to that observed in DDTg mice. Thus, Axin might
influence the function of LEF/TCF factors in the develop-
ment and survival of lymphocytes.
Axin also has a pro-apoptotic activity that appears to be in-
dependent of its effects on the Wnt pathway, as shown by the
induction of apoptosis in several types of cultured cells ex-
pressing elevated levels of Axin (Neo et al., 2000; Satoh et al.,
2000; unpublished data). Besides regulating the Wnt/
 
 
 
-cate-
nin pathway, Axin induces JNK/SAPK activity through its
MEKK1 binding and self-binding domains (Zhang et al.,
1999). Members of the JNK/SAPK family activate an apop-
totic pathway in various cultured cells (Ip and Davis, 1998)
and are required for the induction of neuron-specific apopto-
sis in the development of mouse brain (Yang et al., 1997;
Kuan et al., 1999). It is therefore possible that Axin induces
programmed cell death through a mechanism associated with
its activation of the JNK/SAPK pathway. However, although
programmed cell death occurred in the mammary glands and
lymphoid tissues of DDTg mice, no apoptosis or phenotypic
defects were observed in the testes, where strong expression of
the transgene was also observed (unpublished data). Further-
more, the lack of any effect on the development and prolifera-
tion of the mammary epithelium until the late stages of preg-
nancy in DDTg mice argues against a generalized apoptotic
activity of Axin. Thus, it appears more likely that the apop-
totic effects of Axin are due to the inhibition of Wnt signals
that specifically promote cell survival in certain tissues.
 
Materials and methods
 
Transgene constructs
 
Plasmid pTRE2–Axin–GFP was constructed by first inserting the 1.4-kb
SacII-NotI fragment of IRES and enhanced GFP (pIRES2-GFP; CLONTECH
Laboratories, Inc.) in the same restriction sites upstream of human 
 
 
 
-globin
BamHI-PstI 3
 
 
 
 fragment (h
 
 
 
G3
 
 
 
). The 3.3-kb NheI-AvrII fragment of myc-
tagged, full-length Axin cDNA (Zeng et al., 1997) was added to the NheI
site located 5
 
 
 
 to the IRES2–GFP–h
 
 
 
G3
 
 
 
. The 6.4-kb NheI-EcoRV fragment
of MT–Axin–IRES2–GFP–h
 
 
 
G3
 
 
 
 was then inserted into the same restriction
sites downstream of TRE2, which consisted of seven copies of the tet oper-
ator and a minimal CMV promoter (CLONTECH Laboratories, Inc.).
To create plasmid pMMTV–rtTA, a 1.0-kb blunt-ended EcoRI and
BamHI fragment, which encoded rtTA, was inserted into the blunted NheI
and BamHI sites that are downstream of the LTR of mouse MMTV (1.5-kb
HindIII-SmaI fragment of pMSG vector; Amersham Pharmacia Biotech)
and upstream of h
 
 
 
G3
 
 
 
. Both plasmids contained noncoding exon2,
exon3, and polyadenylation signal of h
 
 
 
G3
 
 
 
 at their 3
 
 
 
 regions to ensure
proper processing of the transcripts.
 
Generation and breeding of transgenic mice
 
All animals were housed under pathogen-free conditions in accordance with
institutional guidelines. Gel-purified 7.4-kb TRE2–Axin–GFP and 4.2-kb
MMTV–rtTA DNA fragments at a concentration of 3 
 
 
 
g/ml were separately
microinjected into the pronuclei of fertilized mouse eggs. The injected em-
bryos were cultured in vitro to the two-cell stage and transferred into the ovi-
ducts of 0.5-d pseudopregnant female mice (Hogan et al., 1994). Mice were
genotyped for the presence of the transgenes by PCR and Southern blot anal-
yses. For PCR, the primers rtTA01, 5
 
 
 
-cattgagatgttagataggc-3
 
 
 
, and rtTA02,
5
 
 -aagttgtttttcttaatccgc-3 , were used to identify the MMTV–rtTA transgene,
Figure 8. Schematic diagram illustrating the proposed mechanism 
by which Axin may interfere with normal mammary gland
development in DDTg mice. Side branching, which requires Wnt-4, 
is not significantly affected by overexpression of Axin. However,
lobulo-alveolar development is severely impaired. This may be due 
to the reduced expression of cyclin D1, a Wnt target gene, which is 
required for lobulo-alveolar development. See text for references. 
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and GFP03, 5 -acggcaagctgaccctgaagt-3 , and GFP04, 5 -gcttctcgttgg-
ggtctttgc-3 , primers were used to identify the TRE2–Axin–GFP transgene.
The PCR reaction for TRE2–Axin–GFP was performed by denaturation at
94 C for 3 min and 35 cycles of amplification (94 C for 1 min, 60 C for 1
min 20 s, and 72 C for 2 min), followed by a 2-min extension at 72 C. To
amplify the MMTV–rtTA transgene, 32 cycles of amplification (94 C for 50 s,
60 C for 1 min 20 s, and 72 C for 2 min) were performed. For Southern anal-
yses, the full-length cDNA of rtTA and GFP were used as probes to detect
the MMTV–rtTA and TRE2–Axin–GFP transgenic mice, respectively.
4 out of 15 MMTV–rtTA founders tested positive for integration of the
transgene by PCR and Southern analyses. One of these lines, MTA4, which
expressed the rtTA as determined by RT-PCR, was used in these studies. 3
out of 29 TRE2–Axin–GFP founders possessed the integrated transgene,
and the two lines TA11 and TA32 were used in these studies. Dox (2 mg/
ml plus 50 mg/ml sucrose) was administrated orally in the drinking water
and replaced three times per week, by diluting a freshly prepared 10 
Dox/sucrose stock solution.
RT-PCR analysis
Total RNA was isolated from tissues of 3-wk-old mice by a guanidine thio-
cyanate/cesium chloride gradient method (Hsu and Chen-Kiang, 1993). 5
 g of total RNA were subjected to first strand cDNA synthesis using the
oligo dT primer (Ambion), followed by PCR amplification of either rtTA or
Hprt. For rtTA, an upstream primer, 5 -ttacgggtctaccatcgagg-3 , within the
rtTA coding sequence and a downstream primer, 5 -ggtggggtgaattctttgcc-
3 , within the noncoding exon3 of h G gene were used to amplify a 445-
bp spliced form of rtTA mRNA transcript. PCR reactions were performed
by denaturation at 94 C for 3 min and 40 cycles of amplification (94 C for
50 s, 58 C for 50 s, and 72 C for 50 s), followed by a 7-min extension at
72 C. For Hprt, a pair of primers (5 -cctgctggattacatataagcactg-3  and 5 -
gtcaagggcatatccaacaacaaac-3 ) was used to amplify a 354-bp fragment of
the Hprt mRNA. PCR reactions were performed by denaturation at 94 C
for 3 min and 33 cycles of amplification (94 C for 30 s, 60 C for 50 s, and
72 C for 50 s), followed by a 7-min extension at 72 C.
Histology and immunohistochemistry
Mouse tissues were dissected in phosphate-buffered saline, fixed in 10%
buffered formalin, and paraffin embedded. Tissues were sectioned, and
stained with hematoxylin and eosin for histological evaluation. Tissue sec-
tions were subject to immunological staining by the use of avidin/biotin-
ylated enzyme complex according to the manufacturer’s protocol (Vector
Laboratories). Mouse monoclonal anti-myc (Ab-1; Calbiochem), anti-
 –catenin (H102; Santa Cruz Biotechnology, Inc.), and anti-CD3  (M-20;
Santa Cruz Biotechnology, Inc.) antibody, and rabbit polyclonal anti-cyc
D1 (Ab-3; NeoMarkers) and anti-pan cytokeratin (Sigma-Aldrich) antibody
were used in these analyses.
Immunoblot analysis
Protein extracts were subject to immunoblotting as previously described
(Hsu et al., 1999). Anti-myc (Ab-1; Calbiochem), anti-cyclin D1 (Ab-3;
NeoMarkers), anti-keratin 14 (K14) (Ab-1; NeoMarkers), anti-Axin (a gift of
Dr. Roel Nusse, Stanford University, Stanford, CA), and anti-casein (a gift
of Dr. Margaret Neville, University of Colorado, Denver, CO) were used as
primary antibodies. Bound antibodies were detected with horseradish per-
oxidase–conjugated secondary antibodies, followed by enhanced chemi-
luminescence–mediated visualization (Amersham Pharmacia Biotech) and
autoradiography.
Whole mount mammary gland staining
The number 4 mammary glands were dissected at the indicated times of de-
velopment and spread on glass slides. After fixation in Carnoy’s fixative for at
least 4 h at room temperature, the tissues were hydrated and stained in car-
mine alum solution overnight as described previously (Robinson et al., 1995).
Samples were then dehydrated, cleared in Histoclear, and photographed.
Apoptosis analysis
In situ TUNEL staining of apoptotic cells in tissue sections was performed
based on the manufacturer’s protocol (Intergen). The staining results were
evaluated by fluorescence microscopy with appropriate excitation and emis-
sion filters. The fluorescent and phase-contrast pictures were taken, and su-
perimposed images were created using Corel PhotoPaint.
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